Center-Authored Papers

Filters: Author is Alberts, David S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Meyskens FL, Mukhtar H, Rock CL, Cuzick J, Kensler TW, Yang CS, Ramsey SD, Lippman SM, Alberts DS.  2016.  Cancer Prevention: Obstacles, Challenges and the Road Ahead.. Journal of the National Cancer Institute. 108(2) Abstract
Lance P, Alberts DS, Thompson PA, Fales L, Wang F, San Jose J, Jacobs ET, Goodman PJ, Darke AK, Yee M et al..  2016.  Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention.. Cancer prevention research (Philadelphia, Pa.). Abstract
E
Skates SJ, Greene MH, Buys SS, Mai PL, Brown PH, Piedmonte M, Rodriguez GC, Schorge JO, Sherman M, Daly MB et al..  2017.  Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
P
Marshall JR, Tangen CM, Sakr WA, Wood DP, Berry DL, Klein EA, Lippman SM, Parnes HL, Alberts DS, Jarrard DF et al..  2011.  Phase III Trial of Selenium to Prevent Prostate Cancer in Men with High-grade Prostatic Intraepithelial Neoplasia: SWOG S9917.. Cancer prevention research (Philadelphia, Pa.). 4(11):1761-9. Abstract
R
Goodman GE, Alberts DS, Meyskens FL.  2008.  Retinol, vitamins, and cancer prevention: 25 years of learning and relearning.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(34):5495-6.
S
Daly MB, Dresher CW, Yates MS, Jeter JM, Karlan BY, Alberts DS, Lu KH.  2015.  Salpingectomy as a Means to Reduce Ovarian Cancer Risk.. Cancer prevention research (Philadelphia, Pa.). 8(5):342-348. Abstract
Markman M, Moon J, Wilczynski S, Lopez AM, Rowland KM, Michelin DP, Lanzotti VJ, Anderson GL, Alberts DS.  2010.  Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: final survival results of a SWOG (S0200) phase 3 randomized trial.. Gynecologic oncology. 116(3):323-5. Abstract